Antiretroviral treatment and immune recovery outcomes in patient health-related quality of life
Bioinformation · 31.10.2026 · 22 (10) · 6735-6738
DOI: 10.6026/973206300226735 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformation, online erschienen am 31.10.2026. Verfasst von Ankita Sharma.
Abstract (Originalsprache)
HIV or AIDS patients'subjective health-related quality of life is an important patient-centered metric for assessing antiretroviral therapy's clinical efficacy. Therefore, it is of interest to examine the short-term effects of continuous pharmacological therapy on immunological recovery and multidimensional functional wellbeing in 152 adult patients admitted to an Indian tertiary care setting. The first treatment phase increased median CD4 counts from 304 to 439 cells/mm3, with large and statistically significant changes in all physical, psychological and environmental domains. These findings show a clear link between early immunological reconstitution and patient well-being and support the routine clinical use of standardized patient-reported outcome measures.
Zitieren
APA
Sharma, A. (2026). Antiretroviral treatment and immune recovery outcomes in patient health-related quality of life. Bioinformation, 22(10), 6735-6738. https://doi.org/10.6026/973206300226735
Vancouver
Sharma A. Antiretroviral treatment and immune recovery outcomes in patient health-related quality of life. Bioinformation. 2026;22(10):6735-6738. doi:10.6026/973206300226735
BibTeX
@article{Sharma2026,
author = {Sharma, Ankita},
title = {Antiretroviral treatment and immune recovery outcomes in patient health-related quality of life},
journal = {Bioinformation},
year = {2026},
volume = {22},
number = {10},
pages = {6735--6738},
doi = {10.6026/973206300226735}
}
EUVIMED